Sionna Therapeutics (SION) Total Current Liabilities (2024 - 2026)

Sionna Therapeutics has disclosed Total Current Liabilities across 3 years of filings, most recently posting $9.8 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $9.8 million, up 2.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.8 million (up 2.61% YoY), and the FY2025 annual result was $11.7 million, up 12.4% from the prior year.
• Total Current Liabilities came in at $9.8 million for Q1 2026 at Sionna Therapeutics, down from $11.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $11.7 million in Q4 2025 to a low of $7.6 million in Q2 2025.
• The 3-year median for Total Current Liabilities is $9.8 million (2025), against an average of $9.8 million.
• Across the five-year window, Total Current Liabilities grew 12.4% in 2025 and gained 2.61% in 2026, its largest moves.
• Sionna Therapeutics' Total Current Liabilities stood at $10.4 million in 2024, then climbed by 12.4% to $11.7 million in 2025, then decreased by 16.53% to $9.8 million in 2026.
• The last three Total Current Liabilities figures came in at $9.8 million (Q1 2026), $11.7 million (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.